These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30408430)

  • 1. PrEP Communications Accelerator: a digital demand creation tool for sub-Saharan Africa.
    Schwartz K; Ferrigno B; Vining S; Gomez A; Briedenhann E; Gardiner E; Jeckonia P; Torjesen K
    Sex Health; 2018 Nov; 15(6):570-577. PubMed ID: 30408430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study.
    Masyuko S; Mukui I; Njathi O; Kimani M; Oluoch P; Wamicwe J; Mutegi J; Njogo S; Anyona M; Muchiri P; Maikweki L; Musyoki H; Bahati P; Kyongo J; Marwa T; Irungu E; Kiragu M; Kioko U; Ogando J; Were D; Bartilol K; Sirengo M; Mugo N; Baeten JM; Cherutich P; PrEP Technical Working Group OBOT
    Sex Health; 2018 Nov; 15(6):578-586. PubMed ID: 30408432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrEP implementation research in Africa: what is new?
    Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
    Eakle R; Weatherburn P; Bourne A
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
    Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
    BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand.
    Phanuphak N; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Seekaew P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Na Nakorn PR; Mills S; Avery M; Vannakit R; Phanuphak P
    Sex Health; 2018 Nov; 15(6):542-555. PubMed ID: 30249317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse-led pre-exposure prophylaxis: a non-traditional model to provide HIV prevention in a resource-constrained, pragmatic clinical trial.
    Schmidt HA; McIver R; Houghton R; Selvey C; McNulty A; Varma R; Grulich AE; Holden J
    Sex Health; 2018 Nov; 15(6):595-597. PubMed ID: 30257752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
    Tung EL; Thomas A; Eichner A; Shalit P
    Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting pre-exposure prophylaxis to high-risk transgender women: lessons from Detroit, USA.
    Hood JE; Eljallad T; Abad J; Connolly M; Heumann C; Fritz J; Roach M; Lukomski D; Golden MR
    Sex Health; 2018 Nov; 15(6):562-569. PubMed ID: 30384881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Likely impact of pre-exposure prophylaxis on HIV epidemics among men who have sex with men.
    Zablotska IB
    Sex Health; 2017 Feb; 14(1):97-105. PubMed ID: 27883309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.
    Dunbar MS; Kripke K; Haberer J; Castor D; Dalal S; Mukoma W; Mullick S; Patel P; Reed J; Subedar H; Were D; Warren M; Torjesen K
    Sex Health; 2018 Nov; 15(6):513-521. PubMed ID: 30408431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
    Bazzi AR; Yotebieng KA; Agot K; Rota G; Syvertsen JL
    AIDS Care; 2018 Mar; 30(3):343-346. PubMed ID: 28780885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and anonymity as factors for the effective implementation of pre-exposure prophylaxis: an observational study among gay, bisexual and other men who have sex with men in Singapore.
    Tan RKJ; Teo AKJ; Kaur N; Harrison-Quintana J; I-Cheng Chen M; Wong CS
    Sex Health; 2018 Nov; 15(6):533-541. PubMed ID: 30249316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.
    Mack N; Odhiambo J; Wong CM; Agot K
    BMC Health Serv Res; 2014 May; 14():231. PubMed ID: 24886646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaling up pre-exposure prophylaxis in sub-Saharan Africa.
    Ahmed N; Pike C; Bekker LG
    Curr Opin Infect Dis; 2019 Feb; 32(1):24-30. PubMed ID: 30461452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eita! Reaching Communities and Young People to Drive Demand for Oral Pre-Exposure Prophylaxis in South Africa.
    Briedenhann E; Rosenberg P; Sheobalak N; Pleaner M; Martin CE; Mullick S
    J Adolesc Health; 2023 Dec; 73(6S):S50-S57. PubMed ID: 37953009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.